Shukra Pharmaceuticals Statistics
Total Valuation
BOM:524632 has a market cap or net worth of INR 18.50 billion. The enterprise value is 18.40 billion.
| Market Cap | 18.50B |
| Enterprise Value | 18.40B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
BOM:524632 has 437.88 million shares outstanding. The number of shares has increased by 68.39% in one year.
| Current Share Class | 437.88M |
| Shares Outstanding | 437.88M |
| Shares Change (YoY) | +68.39% |
| Shares Change (QoQ) | -8.90% |
| Owned by Insiders (%) | 41.59% |
| Owned by Institutions (%) | n/a |
| Float | 46.74M |
Valuation Ratios
The trailing PE ratio is 106.52.
| PE Ratio | 106.52 |
| Forward PE | n/a |
| PS Ratio | 28.65 |
| PB Ratio | 28.11 |
| P/TBV Ratio | 28.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 63.10 |
| EV / Sales | 28.50 |
| EV / EBITDA | 46.79 |
| EV / EBIT | 51.68 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | n/a |
| Interest Coverage | 34.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 51.35% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 8.25% |
| Revenue Per Employee | 5.61M |
| Profits Per Employee | 2.54M |
| Employee Count | 115 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:524632 has paid 68.14 million in taxes.
| Income Tax | 68.14M |
| Effective Tax Rate | 18.94% |
Stock Price Statistics
The stock price has increased by +102.55% in the last 52 weeks. The beta is 0.72, so BOM:524632's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +102.55% |
| 50-Day Moving Average | 48.67 |
| 200-Day Moving Average | 30.93 |
| Relative Strength Index (RSI) | 45.11 |
| Average Volume (20 Days) | 241,886 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524632 had revenue of INR 645.69 million and earned 291.61 million in profits. Earnings per share was 0.40.
| Revenue | 645.69M |
| Gross Profit | 527.17M |
| Operating Income | 356.02M |
| Pretax Income | 359.75M |
| Net Income | 291.61M |
| EBITDA | 393.23M |
| EBIT | 356.02M |
| Earnings Per Share (EPS) | 0.40 |
Balance Sheet
The company has 133.58 million in cash and 37.56 million in debt, with a net cash position of 96.02 million or 0.22 per share.
| Cash & Cash Equivalents | 133.58M |
| Total Debt | 37.56M |
| Net Cash | 96.02M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 658.06M |
| Book Value Per Share | 1.38 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 81.64%, with operating and profit margins of 55.14% and 45.16%.
| Gross Margin | 81.64% |
| Operating Margin | 55.14% |
| Pretax Margin | 55.72% |
| Profit Margin | 45.16% |
| EBITDA Margin | 60.90% |
| EBIT Margin | 55.14% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.02%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.02% |
| Dividend Growth (YoY) | -90.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -68.39% |
| Shareholder Yield | -68.37% |
| Earnings Yield | 1.58% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 21, 2025. It was a forward split with a ratio of 10.
| Last Split Date | Mar 21, 2025 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |